CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024
CBD Life Sciences, Inc. (CBDL) reports unprecedented growth in 2024, with a 1,405.46% increase in revenue as of February. The company's expansion into Amazon and Walmart Marketplace has led to a 300% growth in online sales. CBDL's product line, including Mellow Mornings nano CBD coffee creamers and fast-acting pain relief cream, has seen strong demand with a 500% increase in unit sales for nano CBD products. The company's partnerships with coffee shops have resulted in a 40% increase in CBD-infused beverage orders.
CBDL is also entering the cannabis market through dispensary partnerships, projecting significant revenue growth. The company reports a 40% increase in gross margins year-over-year and expects 2024 revenues to exceed $10 million. CBDL emphasizes its focus on innovation, strategic market entry, and retail partnerships to drive future growth.
CBD Life Sciences, Inc. (CBDL) riporta una crescita senza precedenti nel 2024, con un aumento del 1.405,46% dei ricavi a febbraio. L'espansione dell'azienda in Amazon e Walmart Marketplace ha portato a una crescita del 300% nelle vendite online. La linea di prodotti di CBDL, che include i cremosi al CBD nano Mellow Mornings e la crema analgesica a rapido assorbimento, ha visto una forte domanda con un aumento del 500% nelle vendite unità per i prodotti a base di CBD nano. Le partnership dell'azienda con caffetterie hanno portato a un aumento del 40% negli ordini di bevande infuse con CBD.
CBDL sta anche entrando nel mercato della cannabis attraverso collaborazioni con dispensari, prevedendo una significativa crescita dei ricavi. L'azienda riporta un aumento del 40% nei margini lordi rispetto all'anno precedente e si aspetta che i ricavi del 2024 superino 10 milioni di dollari. CBDL sottolinea il proprio impegno nell'innovazione, nell'ingresso strategico nel mercato e nelle partnership al dettaglio per guidare la crescita futura.
CBD Life Sciences, Inc. (CBDL) informa sobre un crecimiento sin precedentes en 2024, con un aumento del 1,405.46% en ingresos hasta febrero. La expansión de la compañía en Amazon y Walmart Marketplace ha resultando en un crecimiento del 300% en ventas en línea. La línea de productos de CBDL, que incluye cremas para café nano CBD Mellow Mornings y crema para el alivio del dolor de acción rápida, ha visto una fuerte demanda con un aumento del 500% en las ventas unitarias de productos de CBD nano. Las asociaciones de la compañía con cafeterías han resultado en un aumento del 40% en los pedidos de bebidas infusionadas con CBD.
CBDL también está ingresando al mercado de cannabis a través de asociaciones con dispensarios, proyectando un crecimiento significativo en ingresos. La compañía informa un aumento del 40% en los márgenes brutos año tras año y espera que los ingresos de 2024 superen 10 millones de dólares. CBDL enfatiza su enfoque en la innovación, la entrada estratégica en el mercado y las alianzas minoristas para impulsar el crecimiento futuro.
CBD Life Sciences, Inc. (CBDL)은 2024년에 전례 없는 성장을 보고하며, 2월 기준으로 매출이 1,405.46% 증가했습니다. 회사의 Amazon 및 Walmart Marketplace로의 확장은 온라인 판매가 300% 성장하는 결과를 가져왔습니다. CBDL의 제품 라인, 즉 Mellow Mornings 나노 CBD 커피 크리머와 빠르게 작용하는 통증 완화 크림은 나노 CBD 제품의 단위 판매가 500% 증가하는 강력한 수요를 경험했습니다. 회사와 커피숍의 파트너십은 CBD-infused 음료 주문이 40% 증가하는 결과를 초래했습니다.
CBDL은 또한 드ispensary와의 파트너십을 통해 대마초 시장에 진입하고 있으며, 상당한 수익 성장을 예측하고 있습니다. 회사는 전년 대비 총 마진이 40% 증가했다고 보고하며, 2024년 매출이 1,000만 달러를 초과할 것으로 예상합니다. CBDL은 미래 성장을 이끌기 위해 혁신, 전략적 시장 진입 및 소매 파트너십에 집중하고 있음을 강조합니다.
CBD Life Sciences, Inc. (CBDL) annonce une croissance sans précédent en 2024, avec une augmentation des revenus de 1.405,46% en février. L'expansion de l'entreprise sur Amazon et Walmart Marketplace a conduit à une croissance de 300% des ventes en ligne. La gamme de produits de CBDL, y compris les crèmes à café CBD nano Mellow Mornings et la crème analgésique à action rapide, a vu une demande forte avec une augmentation de 500% des ventes unitaires pour les produits CBD nano. Les partenariats de l'entreprise avec des cafés ont entraîné une augmentation de 40% des commandes de boissons infusées au CBD.
CBDL entre également sur le marché du cannabis par des partenariats avec des dispensaires, prévoyant une croissance significative du chiffre d'affaires. L'entreprise rapporte une augmentation de 40% des marges brutes d'année en année et prévoit que les revenus de 2024 dépasseront 10 millions de dollars. CBDL met l'accent sur son engagement en matière d'innovation, d'entrée stratégique sur le marché et de partenariats de détail pour stimuler la croissance future.
CBD Life Sciences, Inc. (CBDL) berichtet von ohnegleichen Wachstum im Jahr 2024, mit einem Umsatzanstieg von 1.405,46% bis Februar. Die Expansion des Unternehmens in den Amazon und Walmart Marketplace führte zu einem Wachstum von 300% im Online-Verkauf. Die Produktpalette von CBDL, einschließlich der Mellow Mornings Nano-CBD-Kaffeecremer und einer schnell wirkenden Schmerzsalbe, verzeichnete eine starke Nachfrage mit einem 500% Anstieg der Stückzahlen für Nano-CBD-Produkte. Die Partnerschaften des Unternehmens mit Cafés führten zu einem 40% Anstieg der Bestellungen von CBD-infusierten Getränken.
CBDL wagt auch den Eintritt in den Cannabismarkt durch Partnerschaften mit Dispensaren und prognostiziert ein signifikantes Umsatzwachstum. Das Unternehmen berichtet von einem 40% Anstieg der Rohmargen im Vergleich zum Vorjahr und erwartet, dass die Umsätze 2024 über 10 Millionen Dollar liegen werden. CBDL legt großen Wert auf Innovation, strategischen Markteintritt und Handelsmarkenpartnerschaften, um zukünftiges Wachstum voranzutreiben.
- 1,405.46% increase in revenue as of February 2024
- 300% growth in online sales since launching on Amazon and Walmart Marketplace
- 500% increase in unit sales for nano CBD products
- 40% increase in customer orders for CBD-infused beverages in partner coffee shops
- 40% increase in gross margins year-over-year
- Projected revenues for 2024 set to surpass $10 million
- Expansion into cannabis market through dispensary partnerships
- None.
"Record-breaking revenue, new market entries, and transformative partnerships highlight our path to increasing shareholder value and long-term growth."
SCOTTSDALE, AZ / ACCESSWIRE / October 8, 2024 / Dear Shareholders,
2024 has been a banner year for CBD Life Sciences, Inc. (CBDL), and we are thrilled to provide you with an exciting corporate update that underscores the massive growth and strategic advancements that are rapidly transforming our business. As of February 2024, we have achieved an extraordinary 1,
This remarkable growth was driven by our aggressive expansion into new retail markets. By entering Amazon and Walmart Marketplace, two of the largest retail platforms globally, we have unlocked access to over
Our product line continues to drive exceptional demand. The launch of our Mellow Mornings nano CBD coffee creamers, along with our fast-acting pain relief cream, has resonated deeply with consumers looking for innovative, effective solutions. In fact, early sales data shows a
Our entrance into the cannabis market, through partnerships with key dispensaries, is expected to fuel additional revenue growth in 2025, with the cannabis industry projected to reach
We are not just scaling, but we are scaling smartly, with a
For shareholders, this means an extraordinary opportunity to capitalize on one of the fastest-growing companies in the CBD space. The company has no intentions of doing reverse split. Our relentless focus on innovation, strategic market entry, and partnerships with leading retailers positions us to not only meet but exceed your expectations in the near future.
Thank you for your continued confidence and trust as we chart a course to even greater heights.
Sincerely,
Lisa Nelson
President & CEO, CBD Life Sciences, Inc.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. (OTC PINK:CBDL) is a forward-thinking, rapidly growing company specializing in the development of innovative, high-quality CBD products designed to enhance health and wellness. From pain relief to stress reduction, CBDL is at the forefront of the CBD revolution, consistently delivering premium products that meet the evolving needs of consumers. With a commitment to cutting-edge science and consumer satisfaction, CBDL is driving growth in the fast-expanding CBD market.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information:
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
FAQ
What was CBDL's revenue growth percentage in 2024?
How much did CBDL's online sales grow after entering Amazon and Walmart Marketplace?
What is the projected revenue for CBDL in 2024?
How much did CBDL's gross margins increase year-over-year?
What new markets is CBDL entering to fuel growth?
